T1	PROC 1 34	Seguimiento de la reactogenicidad
T2	CHEM 41 51	vacuna DTP
#1	AnnotatorNotes T2	C0717718; diphtheria, tetanus toxoids and pertussis vaccine; Immunologic Factor · Pharmacologic Substance | C1277100; Diphtheria-Tetanus-Pertussis Vaccine; Immunologic Factor · Pharmacologic Substance | C3273242; Diphtheria Toxoid/Tetanus Toxoid/Inactivated Pertussis Vaccine; Immunologic Factor · Pharmacologic Substance
T3	CHEM 151 197	vacuna Antidiftérica-Antitetánica-Antipertusis
#2	AnnotatorNotes T3	C0717718; diphtheria, tetanus toxoids and pertussis vaccine; Immunologic Factor · Pharmacologic Substance | C1277100; Diphtheria-Tetanus-Pertussis Vaccine; Immunologic Factor · Pharmacologic Substance | C3273242; Diphtheria Toxoid/Tetanus Toxoid/Inactivated Pertussis Vaccine; Immunologic Factor · Pharmacologic Substance
T4	CHEM 199 202	DTP
#3	AnnotatorNotes T4	C0717718; diphtheria, tetanus toxoids and pertussis vaccine; Immunologic Factor · Pharmacologic Substance | C1277100; Diphtheria-Tetanus-Pertussis Vaccine; Immunologic Factor · Pharmacologic Substance | C3273242; Diphtheria Toxoid/Tetanus Toxoid/Inactivated Pertussis Vaccine; Immunologic Factor · Pharmacologic Substance
T5	PROC 372 423	ensayo clínico (EC) Fase IV, abierto, no controlado
#4	AnnotatorNotes T5	C1709323; Open Label Study; Research Activity + C0681868; Uncontrolled Study; Research Activity + C0282462; Phase 4 Clinical Trials; Research Activity
T6	DISO 530 577	eventos temporalmente asociados a la vacunación
T7	PROC 567 577	vacunación
#5	AnnotatorNotes T7	C0042196; Vaccination; Therapeutic or Preventive Procedure
T8	PROC 744 746	EC
#6	AnnotatorNotes T8	C0008976; Clinical Trials; Research Activity
T9	DISO 775 791	eventos adversos
#7	AnnotatorNotes T9	C0877248; Adverse event; Pathologic Function
T10	DISO 1240 1260	eventos no esperados
T11	DISO 1035 1041	fiebre
#8	AnnotatorNotes T11	C0015967; Fever; Sign or Symptom
T12	DISO 1103 1110	vómitos
#9	AnnotatorNotes T12	C0042963; Vomiting; Sign or Symptom
T13	DISO 1116 1124	anorexia
#10	AnnotatorNotes T13	C0003123; Anorexia; Disease or Syndrome | C1971624; Loss of appetite (finding); Finding
T14	DISO 1129 1140	somnolencia
#11	AnnotatorNotes T14	C0013144; Drowsiness; Finding | C2830004; Somnolence; Mental or Behavioral Dysfunction
T15	PROC 1211 1220	vacunados
#12	AnnotatorNotes T15	C0042196; Vaccination; Therapeutic or Preventive Procedure
T16	PROC 1329 1339	vacunación
#13	AnnotatorNotes T16	C0042196; Vaccination; Therapeutic or Preventive Procedure
T17	DISO 1355 1369	evento adverso
#14	AnnotatorNotes T17	C0877248; Adverse event; Pathologic Function
T18	PROC 1382 1395	hospitalizada
#15	AnnotatorNotes T18	C0019993; Hospitalization; Health Care Activity
T19	DISO 1400 1415	síndrome febril
T20	DISO 1493 1508	sepsis urinaria
#16	AnnotatorNotes T20	C0149801; Sepsis due to urinary tract infection; Disease or Syndrome
T21	DISO 1539 1567	malformación vesico-ureteral
T22	ANAT 1552 1567	vesico-ureteral
T23	DISO 1639 1643	ETAV
T24	DISO 1659 1675	síntomas locales
T25	DISO 1680 1687	eritema
#17	AnnotatorNotes T25	C0041834; Erythema; Disease or Syndrome
T26	DISO 1710 1720	induración
#18	AnnotatorNotes T26	C0332534; Induration; Pathologic Function
T27	DISO 1734 1740	fiebre
#19	AnnotatorNotes T27	C0015967; Fever; Sign or Symptom
T28	DISO 1748 1755	síntoma
#20	AnnotatorNotes T28	C1457887; Symptoms; Sign or Symptom
T29	PROC 1912 1942	vigilancia de eventos adversos
T30	DISO 1926 1942	eventos adversos
#21	AnnotatorNotes T30	C0877248; Adverse event; Pathologic Function
T31	PROC 1949 1951	EC
#22	AnnotatorNotes T31	C0008976; Clinical Trials; Research Activity
T32	DISO 579 583	ETAV
T33	DISO 990 995	dolor
#23	AnnotatorNotes T33	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T34	DISO 1147 1165	llanto persistente
#24	AnnotatorNotes T34	C0558077; Constantly crying; Finding
T35	ANAT 1500 1508	urinaria
#25	AnnotatorNotes T35	C1508753; Urinary system; Body System
T36	ANAT 1805 1813	corporal
#26	AnnotatorNotes T36	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T37	PROC 1960 1976	práctica clínica
T38	CHEM 2061 2067	vacuna
#27	AnnotatorNotes T38	C0042210; Vaccines; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T39	DISO 731 735	ETAV
T41	LIVB 452 461	lactantes
#28	AnnotatorNotes T41	C0021270; Infant; Age Group
T42	LIVB 683 692	lactantes
#29	AnnotatorNotes T42	C0021270; Infant; Age Group
T43	Spec_cue 718 730	sospechas de
T44	CONC 970 985	2da y 3ra dosis
T45	LIVB 853 862	lactantes
#30	AnnotatorNotes T45	C0021270; Infant; Age Group
T47	Neg_cue 1086 1088	No
T48	LIVB 1203 1210	sujetos
#31	AnnotatorNotes T48	C0681850; Study Subject; Group
T50	LIVB 1377 1381	niña
#32	AnnotatorNotes T50	C0870604; Female child; Age Group
T52	PROC 1793 1813	temperatura corporal
#33	AnnotatorNotes T52	C0886414; Body temperature measurement; Health Care Activity
T53	LIVB 2136 2145	lactantes
#34	AnnotatorNotes T53	C0021270; Infant; Age Group
T40	Time 1427 1441	postvacunación
A1	Assertion T39 Speculated
A2	Assertion T12 Negated
A3	Population_data T50 Age
A4	Population_data T53 Age
A5	Population_data T45 Age
A6	Population_data T42 Age
A7	Population_data T41 Age
R1	Negation Arg1:T47 Arg2:T12	
T46	Neg_cue 1773 1775	no
T49	CONC 1776 1789	se especifica
A8	Assertion T49 Negated
#35	AnnotatorNotes T49	C1521902; To specify; Qualitative Concept
R2	Negation Arg1:T46 Arg2:T49	
R3	Location_of Arg1:T36 Arg2:T52	
T51	Neg_cue 410 412	no
T54	Quantifier_or_Qualifier 413 423	controlado
A9	Assertion T54 Negated
R4	Negation Arg1:T51 Arg2:T54	
R5	Causes Arg1:T7 Arg2:T6	
R6	Causes Arg1:T7 Arg2:T32	
#36	AnnotatorNotes T6	C1116172; Vaccination adverse event; Finding | C2721654; Adverse event following immunization; Pathologic Function
#37	AnnotatorNotes T32	C1116172; Vaccination adverse event; Finding | C2721654; Adverse event following immunization; Pathologic Function
#38	AnnotatorNotes T39	C1116172; Vaccination adverse event; Finding | C2721654; Adverse event following immunization; Pathologic Function
R7	Speculation Arg1:T43 Arg2:T39	
R8	Experiences Arg1:T42 Arg2:T39	
R9	Experiences Arg1:T42 Arg2:T6	
R10	Experiences Arg1:T42 Arg2:T32	
T55	Quantifier_or_Qualifier 792 801	esperados
#39	AnnotatorNotes T55	C1517001; Expected (qualifier); Intellectual Product
R12	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T55	
T56	Quantifier_or_Qualifier 1251 1260	esperados
A10	Assertion T56 Negated
#40	AnnotatorNotes T56	C1517001; Expected (qualifier); Intellectual Product
T57	Neg_cue 1248 1250	no
R13	Negation Arg1:T57 Arg2:T56	
R14	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T56	
#41	AnnotatorNotes T10	C1519789; Unexpected Adverse Event; Finding
T58	Quantifier_or_Qualifier 804 815	inesperados
#42	AnnotatorNotes T58	C4055646; Unexpected; Intellectual Product
R15	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T58	
R16	Experiences Arg1:T45 Arg2:T9	
T59	Quantifier_or_Qualifier 888 895	ligeros
R17	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T59	
T60	Quantifier_or_Qualifier 898 924	autolimitados en el tiempo
R18	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T60	
T61	Quantifier_or_Qualifier 1010 1015	local
#43	AnnotatorNotes T61	C0205276; Local; Spatial Concept
R19	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T61	
R20	Overlap Arg1:T9 Arg2:T44	
R21	Experiences Arg1:T48 Arg2:T12	
R22	Experiences Arg1:T48 Arg2:T15	
R23	Experiences Arg1:T48 Arg2:T34	
R24	Experiences Arg1:T48 Arg2:T14	
R25	Experiences Arg1:T48 Arg2:T13	
R26	Before Arg1:T15 Arg2:T12	
R27	Causes Arg1:T15 Arg2:T13	
R28	Causes Arg1:T15 Arg2:T14	
R29	Causes Arg1:T15 Arg2:T34	
R30	Causes Arg1:T16 Arg2:T10	
T62	Quantifier_or_Qualifier 1370 1375	grave
R31	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T62	
R32	Experiences Arg1:T50 Arg2:T17	
#44	AnnotatorNotes T23	C1116172; Vaccination adverse event; Finding | C2721654; Adverse event following immunization; Pathologic Function
T63	Quantifier_or_Qualifier 1416 1426	prolongado
#45	AnnotatorNotes T63	C0439590; Prolonged; Temporal Concept
R35	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T63	
R36	Overlap Arg1:T19 Arg2:T40	
R37	Experiences Arg1:T50 Arg2:T19	
R38	Causes Arg1:T20 Arg2:T19	
R39	Overlap Arg1:T20 Arg2:T40	
R40	Location_of Arg1:T35 Arg2:T20	
T64	Quantifier_or_Qualifier 1509 1520	persistente
R41	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T64	
R42	Causes Arg1:T21 Arg2:T20	
R43	Location_of Arg1:T22 Arg2:T21	
R44	Overlap Arg1:T21 Arg2:T40	
R45	Overlap Arg1:T17 Arg2:T40	
R46	Experiences Arg1:T50 Arg2:T20	
R47	Experiences Arg1:T50 Arg2:T21	
T65	DISO 19 34	reactogenicidad
#46	AnnotatorNotes T65	C5552969; Reactogenicity; Pathologic Function
R53	Causes Arg1:T2 Arg2:T65	
T66	DISO 129 144	reactogenicidad
#47	AnnotatorNotes T66	C5552969; Reactogenicity; Pathologic Function
R54	Causes Arg1:T3 Arg2:T66	
R55	Causes Arg1:T4 Arg2:T66	
T67	DISO 2039 2054	reactogenicidad
#48	AnnotatorNotes T67	C5552969; Reactogenicity; Pathologic Function
R56	Causes Arg1:T38 Arg2:T67	
T68	Quantifier_or_Qualifier 2071 2077	escasa
#49	AnnotatorNotes T68	C0542537; Poor - grade value; Qualitative Concept
R57	Has_Quantifier_or_Qualifier Arg1:T67 Arg2:T68	
T69	Observation 2096 2106	beneficios
#50	AnnotatorNotes T69	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R58	Causes Arg1:T38 Arg2:T69	
R59	Experiences Arg1:T53 Arg2:T69	
R60	Experiences Arg1:T53 Arg2:T38	
R61	Experiences Arg1:T53 Arg2:T67	
R63	After Arg1:T29 Arg2:T38	
R65	Causes Arg1:T38 Arg2:T30	
R66	Experiences Arg1:T53 Arg2:T30	
R33	Experiences Arg1:T50 Arg2:T18	
#51	AnnotatorNotes T59	C2945599; Mild (qualifier value); Qualitative Concept
#52	AnnotatorNotes T62	C1547227; Severe - Severity of Illness Code; Intellectual Product
#53	AnnotatorNotes T64	C0205322; Persistent; Temporal Concept
#54	AnnotatorNotes T54	C4553389; Study Control; Conceptual Entity
#55	AnnotatorNotes T21	C2910238; Malformation of bladder or urethra NOS; Congenital Abnormality (?)
#56	AnnotatorNotes T22	C0545902; urinary bladder and ureter; Body Part, Organ, or Organ Component
A11	Experiencer T41 Patient
A12	Experiencer T42 Patient
A13	Experiencer T45 Patient
A14	Experiencer T48 Patient
A15	Experiencer T50 Patient
A16	Experiencer T53 Patient
